Journal of Thyroid Disorders & Therapy

Journal of Thyroid Disorders & Therapy
Open Access

ISSN: 2167-7948

+44 1300 500008

Irfan Ahmeti

Irfan Ahmeti
University Clinic of Endocrinology, Diabetes and Metabolism,
Skopje
Macedonia

Biography

Dr. Irfan Ahmeti is a distinguished internal medicine specialist at the University Clinic of Endocrinology, Diabetes, and Metabolic Disorders in Skopje, North Macedonia. His clinical expertise encompasses the management of endocrine disorders, with a particular focus on diabetes mellitus and its complications. Throughout his career, Dr. Ahmeti has contributed significantly to medical research. Notably, he co-authored a study titled "Growing Prevalence and Incidence of Diabetes in Republic of Macedonia in the Past 5 Years Based on Data from the National System for Electronic Health Records," which analyzed the increasing trends of diabetes prevalence and incidence in North Macedonia over a five-year period. The study highlighted a 20% increase in registered diabetes cases, emphasizing the need for enhanced public health strategies.

Publications

  • Case Report
    Thyrotoxicosis Associated with Cholestatic Jaundice Treated with Therapeutic Plasma Exchange-Case Report
    Author(s): Irfan Ahmeti, Viktorija Chalovska, Nevena Manevska, Pavlina Dzekova-Vidimliski, Vladimir Avramoski and Daniela Pop GjorcevaIrfan Ahmeti, Viktorija Chalovska, Nevena Manevska, Pavlina Dzekova-Vidimliski, Vladimir Avramoski and Daniela Pop Gjorceva

     Thyroid disorders, especially thyrotoxicosis, are commonly associated with hepatic dysfunction, but cholestasis is rarely reported. Heart failure, infection, weight loss may play role in the pathogenesis of cholestasis. Cholestasis could be worsened by treatment of hyperthyroidism using Thiamazole, but cholestasis in undiagnosed thyrotoxicosis is uncommon. We present 23 year old female with jaundice, goiter, palpitation and confirmed thyrotoxicosis associated with hepatomegaly, hepatocelluar damage and cholestasis. Liver biopsy excluded the suspicion of autoimmune hepatitis. Therapeutic plasma exchange was performed 5 days after starting the treatment with thyroid supressive therapy, and hepatoprotective therapy due to progressive increase of serum levels of bilirubin (conjugated/direct) and liver enzymes. The patient treatment continued with low doses of thyroid suppressive the.. View More»
    DOI: 10.4172/2167-7948.1000211

    Abstract PDF

Relevant Topics

Top